Hikmet Gülben Güç
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hikmet Gülben Güç has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Fatma Tosun
Istanbul Medipol Üniversitesi
2 shared publications - Sevde Nur Biltekin
Department of Pharmaceutical Microbiology, School of Pharmacy, Istanbul Medipol University, 34810 Istanbul, Türkiye
2 shared publications - Hüseyin Onur Tuncay
Faculty of Pharmacy, Department of Pharmaceutical Botany Istanbul University Istanbul Türkiye
1 shared publication - Işık Çelik
Istanbul University
1 shared publication - Tuğba İduğ
Istanbul Medipol University
1 shared publication - Ümit Can Erim
Istanbul Medipol University
1 shared publication
Latest Publications
- 23 October 2026
- Published by Istanbul University in İstanbul Journal of Pharmacy
- Vol. 56 (2) , 209-217
Evaluation of the Cytotoxic, Pro-Apoptotic, and Anti-Inflammatory Activities of Euphorbia oblongifolia (K.Koch) K.Koch Methanolic Extract
Background and Aims: The genus Euphorbia L. is widely recognised for its diverse secondary metabolites with potent biological activities. This study aimed to evaluate the total phenolic content as well as the cytotoxic, pro-apoptotic, and anti-inflammatory potential of the methanolic extract of Euphorbia oblongifolia (K.Koch) K.Koch against various human cancer cell lines and inflammatory models to determine its therapeutic viability.Methods: The total phenolic content was quantified using the Folin-Ciocalteu assay. The cytotoxic effects were assessed using the MTT assay on A549, U87MG, PC3, MCF7 and HEK293 cell lines. Apoptotic induction in PC3 cells was quantified through caspase-3 activity. Anti-inflammatory activity was investigated by measuring protein levels in LPS-stimulated RAW 264.7 macrophages and evaluating the enzymatic inhibition of COX-2 enzyme assays.Results: The E. oblongifolia extract possessed a substantial total phenolic content of 98.95 ± 6.11 mg gallic acid equivalent per gram of dry extract. The extract exhibited selective cytotoxicity against PC3 cells (IC50 = 27.33 ± 1.24 μg/mL) and HEK293 cells (IC50 > 100 μg/mL). Treatment of PC3 cells led to a >2-fold increase in caspase-3 levels, confirming apoptosis. Additionally, the extract suppressed LPS-induced TNF-α production and demonstrated significant COX-2 inhibition, achieving a reduction of over 60% in enzymatic activity.Conclusion: These findings suggest that E. oblongifolia possesses a significant dual-action pharmacological profile underpinned by its rich phenolic yield. By selectively inducing apoptosis in cancer cells and modulating key inflammatory mediators, the extract serves as a promising source for the development of new anticancer and anti-inflammatory agents.
- 23 October 2026
- Published by Istanbul University in İstanbul Journal of Pharmacy
- Vol. 56 (2) , 209-217
Evaluation of the Cytotoxic, Pro-Apoptotic, and Anti-Inflammatory Activities of Euphorbia oblongifolia (K.Koch) K.Koch Methanolic Extract
Background and Aims: The genus Euphorbia L. is widely recognised for its diverse secondary metabolites with potent biological activities. This study aimed to evaluate the total phenolic content as well as the cytotoxic, pro-apoptotic, and anti-inflammatory potential of the methanolic extract of Euphorbia oblongifolia (K.Koch) K.Koch against various human cancer cell lines and inflammatory models to determine its therapeutic viability.Methods: The total phenolic content was quantified using the Folin-Ciocalteu assay. The cytotoxic effects were assessed using the MTT assay on A549, U87MG, PC3, MCF7 and HEK293 cell lines. Apoptotic induction in PC3 cells was quantified through caspase-3 activity. Anti-inflammatory activity was investigated by measuring protein levels in LPS-stimulated RAW 264.7 macrophages and evaluating the enzymatic inhibition of COX-2 enzyme assays.Results: The E. oblongifolia extract possessed a substantial total phenolic content of 98.95 ± 6.11 mg gallic acid equivalent per gram of dry extract. The extract exhibited selective cytotoxicity against PC3 cells (IC50 = 27.33 ± 1.24 μg/mL) and HEK293 cells (IC50 > 100 μg/mL). Treatment of PC3 cells led to a >2-fold increase in caspase-3 levels, confirming apoptosis. Additionally, the extract suppressed LPS-induced TNF-α production and demonstrated significant COX-2 inhibition, achieving a reduction of over 60% in enzymatic activity.Conclusion: These findings suggest that E. oblongifolia possesses a significant dual-action pharmacological profile underpinned by its rich phenolic yield. By selectively inducing apoptosis in cancer cells and modulating key inflammatory mediators, the extract serves as a promising source for the development of new anticancer and anti-inflammatory agents.
- 3 August 2026
- Published by Marmara University in Journal of Research in Pharmacy
- Vol. 30 (4) , 1055-1063
Selective cytotoxicity of Heracleum platytaenium and Selinum alatum in PC3 cells: Involvement of MAPK inhibition and caspase-3 activation
This study systematically evaluated the in vitro cytotoxic potential of four plant extracts from the Apiaceae family—Artedia squamata L., Astrantia maxima Pall. subsp. maxima, Heracleum platytaenium Boiss., and Selinum alatum(M.Bieb.) Poir.—against a panel of human carcinoma cell lines (A549, PC3, MCF7, and U87MG), providing novel insights into the dynamics of oncogenic progression through advanced analyses. Notably, this research represents the first comprehensive report on the anti-proliferative activities of these specific extracts against both malignant and non-malignant human cell lines. Our findings, obtained via the MTT assay using colchicine as a positive control, reveal that H. platytaenium and S. alatum are highly potent cytotoxic agents, exhibiting remarkably low IC50 values. Crucially, while the positive control colchicine proved highly toxic to healthy cells (IC50 = 31.27 ± 1.03 µg/mL), all investigated extracts demonstrated an exceptional safety profile, showing no significant cytotoxicity against the non-malignant human embryonic kidney cell line (HEK293, IC50 > 100 µg/mL). The high selectivity index of these extracts, evidenced by their robust inhibition of malignant cells coupled with their biocompatibility with normal tissues, underscores their pharmacological significance. Furthermore, the significant inhibitory effects of these potent extracts on the MAPK pathway—a master regulator of carcinogenesis—alongside their modulation of Caspase-3 activity, constitute substantial data newly contributed to the literature. These results identify the studied taxa, particularly H. platytaenium, as promising and safe natural candidates for the discovery of novel anticancer therapeutics, warranting further investigation.
- 3 August 2026
- Published by Marmara University in Journal of Research in Pharmacy
- Vol. 30 (4) , 1055-1063
Selective cytotoxicity of Heracleum platytaenium and Selinum alatum in PC3 cells: Involvement of MAPK inhibition and caspase-3 activation
This study systematically evaluated the in vitro cytotoxic potential of four plant extracts from the Apiaceae family—Artedia squamata L., Astrantia maxima Pall. subsp. maxima, Heracleum platytaenium Boiss., and Selinum alatum(M.Bieb.) Poir.—against a panel of human carcinoma cell lines (A549, PC3, MCF7, and U87MG), providing novel insights into the dynamics of oncogenic progression through advanced analyses. Notably, this research represents the first comprehensive report on the anti-proliferative activities of these specific extracts against both malignant and non-malignant human cell lines. Our findings, obtained via the MTT assay using colchicine as a positive control, reveal that H. platytaenium and S. alatum are highly potent cytotoxic agents, exhibiting remarkably low IC50 values. Crucially, while the positive control colchicine proved highly toxic to healthy cells (IC50 = 31.27 ± 1.03 µg/mL), all investigated extracts demonstrated an exceptional safety profile, showing no significant cytotoxicity against the non-malignant human embryonic kidney cell line (HEK293, IC50 > 100 µg/mL). The high selectivity index of these extracts, evidenced by their robust inhibition of malignant cells coupled with their biocompatibility with normal tissues, underscores their pharmacological significance. Furthermore, the significant inhibitory effects of these potent extracts on the MAPK pathway—a master regulator of carcinogenesis—alongside their modulation of Caspase-3 activity, constitute substantial data newly contributed to the literature. These results identify the studied taxa, particularly H. platytaenium, as promising and safe natural candidates for the discovery of novel anticancer therapeutics, warranting further investigation.
- 22 February 2026
- Published by Wiley in Biomedical Chromatography
- Vol. 40 (4) , e70402
Comparative Evaluation of Extraction Methods for Optimising Phenolics and Antioxidant Activity in Tribulus terrestris
The medicinal plant Tribulus terrestris L. (TT) contains antioxidant and pharmacologically active phenolic compounds. However, extraction procedures can greatly affect extract yield, composition and biological activity. This study evaluated how conventional and advanced extraction methods affected TT extracts' phenolic content and antioxidant activity. TT was extracted using maceration, Soxhlet, ultrasound‐assisted extraction (UAE) and microwave‐assisted extraction (MAE) with ethanol–water solvent systems applied for different extraction times. The extracts were assessed for total phenolic content (TPC), total phenolic acid content (TPAC) and antioxidant capacity through 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH), cupric ion reducing antioxidant capacity (CUPRAC) and ferric reducing antioxidant power (FRAP) assays. Phenolic acid composition was analysed by HPLC. TPC values ranged between 27.66 and 37.98 mg GAE/g and TPAC between 8.273 and 24.337 mg CAE/g. Antioxidant activity (IC 50 ) varied from 0.1132 to 0.1904 mg/mL, with UAE (80:20, 10 min) demonstrating the highest DPPH activity. CUPRAC and FRAP values extended from 97.462 to 308.769 mg TE/g and 8.917–17.291 mg TE/g, respectively, with UAE consistently yielding the most active extracts. HPLC detected eight phenolic acids, with protocatechuic acid (2.794 mg/g extract) being the most abundant, followed by p ‐coumaric, chlorogenic and caffeic acids. The extraction method affected the TT extracts' phenolic content and antioxidant capability. The UAE produced the highest phenolic‐rich and bioactive extract. To maximise T. terrestris ' phytochemical and nutraceutical potential, extraction procedures need to be optimised.
- 22 February 2026
- Published by Wiley in Biomedical Chromatography
- Vol. 40 (4) , e70402
Comparative Evaluation of Extraction Methods for Optimising Phenolics and Antioxidant Activity in Tribulus terrestris
The medicinal plant Tribulus terrestris L. (TT) contains antioxidant and pharmacologically active phenolic compounds. However, extraction procedures can greatly affect extract yield, composition and biological activity. This study evaluated how conventional and advanced extraction methods affected TT extracts' phenolic content and antioxidant activity. TT was extracted using maceration, Soxhlet, ultrasound‐assisted extraction (UAE) and microwave‐assisted extraction (MAE) with ethanol–water solvent systems applied for different extraction times. The extracts were assessed for total phenolic content (TPC), total phenolic acid content (TPAC) and antioxidant capacity through 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH), cupric ion reducing antioxidant capacity (CUPRAC) and ferric reducing antioxidant power (FRAP) assays. Phenolic acid composition was analysed by HPLC. TPC values ranged between 27.66 and 37.98 mg GAE/g and TPAC between 8.273 and 24.337 mg CAE/g. Antioxidant activity (IC 50 ) varied from 0.1132 to 0.1904 mg/mL, with UAE (80:20, 10 min) demonstrating the highest DPPH activity. CUPRAC and FRAP values extended from 97.462 to 308.769 mg TE/g and 8.917–17.291 mg TE/g, respectively, with UAE consistently yielding the most active extracts. HPLC detected eight phenolic acids, with protocatechuic acid (2.794 mg/g extract) being the most abundant, followed by p ‐coumaric, chlorogenic and caffeic acids. The extraction method affected the TT extracts' phenolic content and antioxidant capability. The UAE produced the highest phenolic‐rich and bioactive extract. To maximise T. terrestris ' phytochemical and nutraceutical potential, extraction procedures need to be optimised.